Skip to Main Content

Paper Details

Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study.
Clinicoecon Outcomes Res
2
2023
ASCVD, CNIC, Patients, aspirin, atherosclerotic cardiovascular disease, atorvastatin, cardiovascular, cardiovascular events, patient, patients, ramipril
Author NameAffiliation
Valentin FusterNational Center for Cardiovascular Research (CNIC), Carlos III Health Institute
Valentin FusterMount Sinai Medical Center
Jos?? M CastellanoNational Center for Cardiovascular Research (CNIC), Carlos III Health Institute
Jos?? M CastellanoIntegral Center for Cardiovascular Diseases (CIEC), Monteprincipe University Hospital, HM Hospitales Group
Jos?? M CastellanoCEU San Pablo University
  • 1 - 5

Datasets

Release 1.2